HIV-Associated Lipodystrophy Syndrome

Search with Google Search with Bing
Information
Disease name
HIV-Associated Lipodystrophy Syndrome
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT04340388 Completed Phase 4 Contribution of Dolutegravir to Obesity and Cardiovascular Disease September 17, 2020 February 25, 2023
NCT00383734 Completed Phase 3 Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILE December 2006 September 2010
NCT00646984 Completed Phase 4 Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy January 2002 April 2006
NCT01359917 Completed Psychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment Outcome August 2006 July 2009
NCT01848340 Completed Phase 1 An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects May 2013 July 2013
NCT00069004 Completed A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and Youth October 2003 August 2005
NCT00130286 Completed Phase 1/Phase 2 Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance March 2005 August 2010
NCT00135356 Completed Phase 4 Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome July 2005 June 2008
NCT00192660 Completed Phase 4 HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001) February 2003 December 2007
NCT00122668 Terminated Phase 4 Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients November 2003 July 2005
NCT00148850 Terminated Phase 3 Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 Patients February 2003 October 2004
NCT00122226 Unknown status Phase 4 MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS) January 2003 July 2008
NCT00662181 Unknown status Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone May 2008 January 2009
NCT00135460 Unknown status Phase 4 Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in HIV Infected Patients June 2003 November 2007
MeSH unique ID (MeSH (Medical Subject Headings))
D039682